Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Kuczyk

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
British Journal of Urology|July 1, 1997
Prognostic relevance of intracaval neoplastic extension for patients with renal cell cancerM A Kuczyk, C Bokemeyer, G Köhn, et al.
Oncology Letters|June 29, 2012
Fibronectin 1 protein expression in clear cell renal cell carcinomaS Steffens, A J Schrader, Gesa Vetter, et al.
Andrologia|August 9, 2017
Expression and distribution of key proteins of the endocannabinoid system in the human seminal vesiclesS Ückert, G la Croce, A Bettiga, et al.
World Journal of Urology|June 21, 2002
Recent strategies for the use of paclitaxel in the treatment of urological malignanciesC Bokemeyer, J T Hartmann, M A Kuczyk, et al.
Oncology Reports|February 12, 1998
The MXI1 tumor suppressor gene is not mutated in primary prostate cancerM A Kuczyk, J Serth, C Bokemeyer, et al.
Georgian Medical News|April 24, 2010
C-kit-positive multipolar cells in human penile erectile tissue: expression of connexin 43 and relation to trabecular smooth muscle cellsS Uckert, G T Kedia, I Satzger, et al.
Der Urologe. Ausg. A|April 9, 2009
[Significance of phosphodiesterase isoenzymes in the control of human detrusor smooth muscle function. An immunohistochemical and functional study]S Uckert, K Sigl, E S Waldkirch, et al.
International Journal of Cancer|December 20, 1995
Detection of p53 gene alteration in renal-cell cancer by micropreparation techniques of tumor specimensM A Kuczyk, J Serth, C Bokemeyer, et al.
Der Urologe. Ausg. A|July 2, 2011
[Overweight is an advantageous prognostic marker in patients with clear cell kidney cancer]S Waalkes, H Eggers, J Rustemeier, et al.
Der Urologe. Ausg. A|August 6, 2008
[Methylation of the RASSF1A tumor suppressor gene promoter. Risk factor for carcinogenesis of urological tumors]J Serth, H Tezval, I Peters, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
British Journal of Urology|July 1, 1997
Prognostic relevance of intracaval neoplastic extension for patients with renal cell cancerM A Kuczyk, C Bokemeyer, G Köhn, et al.
Oncology Letters|June 29, 2012
Fibronectin 1 protein expression in clear cell renal cell carcinomaS Steffens, A J Schrader, Gesa Vetter, et al.
Andrologia|August 9, 2017
Expression and distribution of key proteins of the endocannabinoid system in the human seminal vesiclesS Ückert, G la Croce, A Bettiga, et al.
World Journal of Urology|June 21, 2002
Recent strategies for the use of paclitaxel in the treatment of urological malignanciesC Bokemeyer, J T Hartmann, M A Kuczyk, et al.
Oncology Reports|February 12, 1998
The MXI1 tumor suppressor gene is not mutated in primary prostate cancerM A Kuczyk, J Serth, C Bokemeyer, et al.
Georgian Medical News|April 24, 2010
C-kit-positive multipolar cells in human penile erectile tissue: expression of connexin 43 and relation to trabecular smooth muscle cellsS Uckert, G T Kedia, I Satzger, et al.
Der Urologe. Ausg. A|April 9, 2009
[Significance of phosphodiesterase isoenzymes in the control of human detrusor smooth muscle function. An immunohistochemical and functional study]S Uckert, K Sigl, E S Waldkirch, et al.
International Journal of Cancer|December 20, 1995
Detection of p53 gene alteration in renal-cell cancer by micropreparation techniques of tumor specimensM A Kuczyk, J Serth, C Bokemeyer, et al.
Der Urologe. Ausg. A|July 2, 2011
[Overweight is an advantageous prognostic marker in patients with clear cell kidney cancer]S Waalkes, H Eggers, J Rustemeier, et al.
Der Urologe. Ausg. A|August 6, 2008
[Methylation of the RASSF1A tumor suppressor gene promoter. Risk factor for carcinogenesis of urological tumors]J Serth, H Tezval, I Peters, et al.
Pageof 10